This page shows Celanese Corp Del (CE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Celanese Corp Del has an operating margin of -8.2%, meaning the company retains $-8 of operating profit per $100 of revenue. This below-average margin results in a low score of 4/100, suggesting thin profitability after operating expenses. This is down from -7.0% the prior year.
Celanese Corp Del's revenue declined 7.1% year-over-year, from $10.3B to $9.5B. This contraction results in a growth score of 22/100.
Celanese Corp Del has a moderate D/E ratio of 3.12. This balance of debt and equity financing earns a leverage score of 38/100.
Celanese Corp Del's current ratio of 1.55 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 27/100, which could limit financial flexibility.
Celanese Corp Del has a free cash flow margin of 8.4%, earning a moderate score of 46/100. The company generates positive cash flow after capital investments, but with room for improvement.
Celanese Corp Del generates a -28.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -30.1% the prior year.
Celanese Corp Del passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Celanese Corp Del generates $-0.98 in operating cash flow ($1.1B OCF vs -$1.2B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Celanese Corp Del earns $-1.1 in operating income for every $1 of interest expense (-$786.0M vs $701.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Celanese Corp Del generated $9.5B in revenue in fiscal year 2025. This represents a decrease of 7.1% from the prior year.
Celanese Corp Del's EBITDA was -$26.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 132.1% from the prior year.
Celanese Corp Del reported -$1.2B in net income in fiscal year 2025. This represents an increase of 24.4% from the prior year.
Celanese Corp Del earned $-10.64 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.6% from the prior year.
Cash & Balance Sheet
Celanese Corp Del generated $803.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 51.2% from the prior year.
Celanese Corp Del held $1.3B in cash against $12.6B in long-term debt as of fiscal year 2025.
Margins & Returns
Celanese Corp Del's gross margin was 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.3 percentage points from the prior year.
Celanese Corp Del's operating margin was -8.2% in fiscal year 2025, reflecting core business profitability. This is down 1.2 percentage points from the prior year.
Celanese Corp Del's net profit margin was -12.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.8 percentage points from the prior year.
Celanese Corp Del's ROE was -28.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the prior year.
Capital Allocation
Celanese Corp Del invested $125.0M in research and development in fiscal year 2025. This represents a decrease of 3.8% from the prior year.
Celanese Corp Del invested $343.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 21.1% from the prior year.
CE Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B-8.9% | $2.4B-4.5% | $2.5B+6.0% | $2.4B+1.3% | $2.4B-11.0% | $2.6B-0.1% | $2.7B+1.5% | $2.6B |
| Cost of Revenue | $1.8B-6.0% | $1.9B-5.0% | $2.0B+4.4% | $1.9B+4.2% | $1.8B-9.5% | $2.0B+0.9% | $2.0B-2.3% | $2.1B |
| Gross Profit | $420.0M-19.4% | $521.0M-2.6% | $535.0M+12.4% | $476.0M-8.8% | $522.0M-15.7% | $619.0M-3.4% | $641.0M+15.7% | $554.0M |
| R&D Expenses | $32.0M+3.2% | $31.0M0.0% | $31.0M0.0% | $31.0M0.0% | $31.0M-3.1% | $32.0M-3.0% | $33.0M-2.9% | $34.0M |
| SG&A Expenses | $225.0M-2.6% | $231.0M+8.5% | $213.0M-7.4% | $230.0M-13.2% | $265.0M+6.9% | $248.0M-2.7% | $255.0M-3.8% | $265.0M |
| Operating Income | $88.0M+106.9% | -$1.3B-647.2% | $233.0M+38.7% | $168.0M+111.8% | -$1.4B-681.6% | $245.0M-2.0% | $250.0M+19.0% | $210.0M |
| Interest Expense | $177.0M0.0% | $177.0M0.0% | $177.0M+4.1% | $170.0M+3.7% | $164.0M-3.0% | $169.0M-2.9% | $174.0M+3.0% | $169.0M |
| Income Tax | -$15.0M-114.3% | -$7.0M+90.9% | -$77.0M-955.6% | $9.0M-97.7% | $384.0M+529.5% | $61.0M+110.3% | $29.0M-12.1% | $33.0M |
| Net Income | $14.0M+101.0% | -$1.4B-781.9% | $199.0M+1047.6% | -$21.0M+98.9% | -$1.9B-1808.8% | $113.0M-27.1% | $155.0M+28.1% | $121.0M |
| EPS (Diluted) | N/A | $-12.39-784.5% | $1.81+1052.6% | $-0.19 | N/A | $1.03-27.0% | $1.41+28.2% | $1.10 |
CE Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.7B-2.1% | $22.2B-6.5% | $23.7B+2.2% | $23.2B+1.6% | $22.8B-11.8% | $25.9B+0.3% | $25.8B-0.8% | $26.0B |
| Current Assets | $5.7B-6.5% | $6.1B+7.3% | $5.7B+4.7% | $5.4B+5.7% | $5.1B-10.2% | $5.7B-3.4% | $5.9B-0.7% | $5.9B |
| Cash & Equivalents | $1.3B-12.3% | $1.4B+22.8% | $1.2B+23.3% | $951.0M-1.1% | $962.0M+18.3% | $813.0M-31.4% | $1.2B-20.1% | $1.5B |
| Inventory | $2.2B+0.3% | $2.2B-3.3% | $2.3B-0.9% | $2.3B+1.1% | $2.3B-10.9% | $2.6B+4.0% | $2.5B+4.7% | $2.4B |
| Accounts Receivable | $922.0M-11.2% | $1.0B-14.6% | $1.2B-1.9% | $1.2B+10.6% | $1.1B-18.0% | $1.4B+8.1% | $1.3B-1.9% | $1.3B |
| Goodwill | $4.2B0.0% | $4.2B-23.7% | $5.5B+1.0% | $5.4B+0.5% | $5.4B-23.0% | $7.0B+1.4% | $6.9B-0.4% | $6.9B |
| Total Liabilities | $17.6B-3.1% | $18.2B-1.2% | $18.4B+2.4% | $18.0B+1.7% | $17.7B-5.1% | $18.7B-0.1% | $18.7B-1.6% | $19.0B |
| Current Liabilities | $3.7B-1.2% | $3.7B+34.7% | $2.8B-1.1% | $2.8B-28.1% | $3.9B-6.5% | $4.2B-10.1% | $4.6B-6.1% | $4.9B |
| Long-Term Debt | $12.6B-1.2% | $12.8B-0.9% | $12.9B+2.5% | $12.6B+0.2% | $12.5B-1.8% | $12.8B-1.8% | $13.0B-3.3% | $13.4B |
| Total Equity | $4.0B+2.4% | $4.0B-25.1% | $5.3B+1.7% | $5.2B+1.1% | $5.1B-29.1% | $7.2B+1.3% | $7.1B+1.1% | $7.1B |
| Retained Earnings | $9.9B+0.2% | $9.9B-12.3% | $11.2B+1.5% | $11.1B+0.2% | $11.1B-15.6% | $13.1B+0.3% | $13.1B+0.6% | $13.0B |
CE Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $252.0M-43.6% | $447.0M+9.0% | $410.0M+1008.1% | $37.0M-92.5% | $494.0M+525.3% | $79.0M-72.9% | $292.0M+189.1% | $101.0M |
| Capital Expenditures | $84.0M+31.3% | $64.0M-31.2% | $93.0M-8.8% | $102.0M-2.9% | $105.0M+19.3% | $88.0M-16.2% | $105.0M-23.4% | $137.0M |
| Free Cash Flow | $168.0M-56.1% | $383.0M+20.8% | $317.0M+587.7% | -$65.0M-116.7% | $389.0M+4422.2% | -$9.0M-104.8% | $187.0M+619.4% | -$36.0M |
| Investing Cash Flow | -$104.0M-76.3% | -$59.0M+33.0% | -$88.0M+10.2% | -$98.0M+23.4% | -$128.0M-28.0% | -$100.0M-9.9% | -$91.0M+39.7% | -$151.0M |
| Financing Cash Flow | -$324.0M-174.6% | -$118.0M-1.7% | -$116.0M-357.8% | $45.0M+123.8% | -$189.0M+49.7% | -$376.0M+23.1% | -$489.0M-88.8% | -$259.0M |
| Dividends Paid | $4.0M+33.3% | $3.0M0.0% | $3.0M0.0% | $3.0M-96.1% | $77.0M+1.3% | $76.0M-1.3% | $77.0M0.0% | $77.0M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CE Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.1%-2.5pp | 21.5%+0.4pp | 21.1%+1.2pp | 19.9%-2.2pp | 22.1%-1.2pp | 23.4%-0.8pp | 24.2%+3.0pp | 21.2% |
| Operating Margin | 4.0%+56.7pp | -52.7%-61.9pp | 9.2%+2.2pp | 7.0%+67.5pp | -60.4%-69.7pp | 9.3%-0.2pp | 9.4%+1.4pp | 8.0% |
| Net Margin | 0.6%+56.7pp | -56.1%-64.0pp | 7.9%+8.7pp | -0.9%+81.0pp | -81.9%-86.2pp | 4.3%-1.6pp | 5.9%+1.2pp | 4.6% |
| Return on Equity | 0.4%+34.7pp | -34.3%-38.1pp | 3.8%+4.2pp | -0.4%+37.3pp | -37.6%-39.2pp | 1.6%-0.6pp | 2.2%+0.5pp | 1.7% |
| Return on Assets | 0.1%+6.2pp | -6.1%-7.0pp | 0.8%+0.9pp | -0.1%+8.4pp | -8.5%-8.9pp | 0.4%-0.2pp | 0.6%+0.1pp | 0.5% |
| Current Ratio | 1.55-0.1 | 1.63-0.4 | 2.05+0.1 | 1.94+0.6 | 1.32-0.1 | 1.37+0.1 | 1.28+0.1 | 1.21 |
| Debt-to-Equity | 3.12-0.1 | 3.23+0.8 | 2.44+0.0 | 2.42-0.0 | 2.44+0.7 | 1.76-0.1 | 1.82-0.1 | 1.90 |
| FCF Margin | 7.6%-8.2pp | 15.8%+3.3pp | 12.5%+15.2pp | -2.7%-19.2pp | 16.5%+16.8pp | -0.3%-7.4pp | 7.0%+8.4pp | -1.4% |
Similar Companies
Frequently Asked Questions
What is Celanese Corp Del's annual revenue?
Celanese Corp Del (CE) reported $9.5B in total revenue for fiscal year 2025. This represents a -7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Celanese Corp Del's revenue growing?
Celanese Corp Del (CE) revenue declined by 7.1% year-over-year, from $10.3B to $9.5B in fiscal year 2025.
Is Celanese Corp Del profitable?
No, Celanese Corp Del (CE) reported a net income of -$1.2B in fiscal year 2025, with a net profit margin of -12.2%.
What is Celanese Corp Del's EBITDA?
Celanese Corp Del (CE) had EBITDA of -$26.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Celanese Corp Del have?
As of fiscal year 2025, Celanese Corp Del (CE) had $1.3B in cash and equivalents against $12.6B in long-term debt.
What is Celanese Corp Del's gross margin?
Celanese Corp Del (CE) had a gross margin of 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Celanese Corp Del's operating margin?
Celanese Corp Del (CE) had an operating margin of -8.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Celanese Corp Del's net profit margin?
Celanese Corp Del (CE) had a net profit margin of -12.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Celanese Corp Del's return on equity (ROE)?
Celanese Corp Del (CE) has a return on equity of -28.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Celanese Corp Del's free cash flow?
Celanese Corp Del (CE) generated $803.0M in free cash flow during fiscal year 2025. This represents a 51.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Celanese Corp Del's operating cash flow?
Celanese Corp Del (CE) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Celanese Corp Del's total assets?
Celanese Corp Del (CE) had $21.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Celanese Corp Del's capital expenditures?
Celanese Corp Del (CE) invested $343.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Celanese Corp Del spend on research and development?
Celanese Corp Del (CE) invested $125.0M in research and development during fiscal year 2025.
What is Celanese Corp Del's current ratio?
Celanese Corp Del (CE) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.
What is Celanese Corp Del's debt-to-equity ratio?
Celanese Corp Del (CE) had a debt-to-equity ratio of 3.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Celanese Corp Del's return on assets (ROA)?
Celanese Corp Del (CE) had a return on assets of -5.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Celanese Corp Del's Piotroski F-Score?
Celanese Corp Del (CE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Celanese Corp Del's earnings high quality?
Celanese Corp Del (CE) has an earnings quality ratio of -0.98x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Celanese Corp Del cover its interest payments?
Celanese Corp Del (CE) has an interest coverage ratio of -1.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Celanese Corp Del?
Celanese Corp Del (CE) scores 23 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.